NCI | Technology Transfer

Identification Of A Dominant B Cell Epitope From NY-ESO-1: Implications For Antibody Detection Against Tumor-associated Antigens

Read more about Identification Of A Dominant B Cell Epitope From NY-ESO-1: Implications For Antibody Detection Against Tumor-associated Antigens

US Application 60/572,474
Filed on 2004-05-20

Peptide And Peptidomimetic Inhibitors Of Smoothened Protein As Anti-neoplastic Agents

Read more about Peptide And Peptidomimetic Inhibitors Of Smoothened Protein As Anti-neoplastic Agents

US Application 60/855,422
Filed on 2006-10-31

Aviden-Rhpdaminex (AV-3ROX) As A Self-Quenching Fluorophore Useful In Imaging Technology

Read more about Aviden-Rhpdaminex (AV-3ROX) As A Self-Quenching Fluorophore Useful In Imaging Technology

US Application 60/922,801
Filed on 2007-04-10

CKAP4/p63 Is A Bladder Epithelial Cell Bladder Cell Receptor For The Antiproliferative Factor (APF) From Interstitial Cystitis Patients

Read more about CKAP4/p63 Is A Bladder Epithelial Cell Bladder Cell Receptor For The Antiproliferative Factor (APF) From Interstitial Cystitis Patients

US Application 60/833,828
Filed on 2006-07-27

Methods And Compositions For Assessing Alterations In Gene Expression Patterns In Clinically Normal Tissues Obtained From Heterozygous Carriers Of Mutant Genes Associated With Cancer And Methods Of Use Thereof

Read more about Methods And Compositions For Assessing Alterations In Gene Expression Patterns In Clinically Normal Tissues Obtained From Heterozygous Carriers Of Mutant Genes Associated With Cancer And Methods Of Use Thereof

US Application 60/840,842
Filed on 2006-08-29

Methods And Compositions For Assessing Alterations In Gene Expression Patterns In Clinically Normal Tissues Obtained From Heterozygous Carriers Of Mutant Genes Associated With Cancer And Methods Of Use Thereof

Read more about Methods And Compositions For Assessing Alterations In Gene Expression Patterns In Clinically Normal Tissues Obtained From Heterozygous Carriers Of Mutant Genes Associated With Cancer And Methods Of Use Thereof

US Application 60/749,234
Filed on 2005-12-09

MODIFIED T CELL RECEPTORS AND RELATED MATERIALS AND METHODS

Read more about MODIFIED T CELL RECEPTORS AND RELATED MATERIALS AND METHODS

US Application 60/847,447
Filed on 2006-09-26

SCGB3A2 AS A GROWTH FACTOR AND ANTI-APOPTOTIC AGENT

Read more about SCGB3A2 AS A GROWTH FACTOR AND ANTI-APOPTOTIC AGENT

US Application 60/847,747
Filed on 2006-09-27

Compositions and Methods for Chitosan Enhanced Immune Response

Read more about Compositions and Methods for Chitosan Enhanced Immune Response

US Application 60/846,481
Filed on 2006-09-22

Synthesis And Use Of Two Protected Variants Of The 1B4M DTPA

Read more about Synthesis And Use Of Two Protected Variants Of The 1B4M DTPA

US Application 60/864,503
Filed on 2006-11-06

Subscribe to NCI